THERESE RAMIREZ: Open Payments
NPI 1871543207 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 20 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $498 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $410 |
| Boston Scientific Corporation | 1 | $136 |
| Novo Nordisk Inc | 1 | $105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $102 |
| Smith+Nephew, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: SKYRIZI, WATCHMAN FLX, Wegovy, XIFAXAN, RINVOQ, CREON, COLLAGENASE SANTYL, IQIRVO.
Industry payments across TX — which companies pay providers there.
